232 related articles for article (PubMed ID: 30010126)
21. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
[TBL] [Abstract][Full Text] [Related]
22. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
23. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD
Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349
[TBL] [Abstract][Full Text] [Related]
24. Staging TDP-43 pathology in Alzheimer's disease.
Josephs KA; Murray ME; Whitwell JL; Parisi JE; Petrucelli L; Jack CR; Petersen RC; Dickson DW
Acta Neuropathol; 2014 Mar; 127(3):441-50. PubMed ID: 24240737
[TBL] [Abstract][Full Text] [Related]
25. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
26. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.
Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682
[TBL] [Abstract][Full Text] [Related]
27. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
[TBL] [Abstract][Full Text] [Related]
28. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
[TBL] [Abstract][Full Text] [Related]
29. Updated TDP-43 in Alzheimer's disease staging scheme.
Josephs KA; Murray ME; Whitwell JL; Tosakulwong N; Weigand SD; Petrucelli L; Liesinger AM; Petersen RC; Parisi JE; Dickson DW
Acta Neuropathol; 2016 Apr; 131(4):571-85. PubMed ID: 26810071
[TBL] [Abstract][Full Text] [Related]
30. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.
Josephs KA; Whitwell JL; Knopman DS; Hu WT; Stroh DA; Baker M; Rademakers R; Boeve BF; Parisi JE; Smith GE; Ivnik RJ; Petersen RC; Jack CR; Dickson DW
Neurology; 2008 May; 70(19 Pt 2):1850-7. PubMed ID: 18401022
[TBL] [Abstract][Full Text] [Related]
31. TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.
Jung Y; Dickson DW; Murray ME; Whitwell JL; Knopman DS; Boeve BF; Jack CR; Parisi JE; Petersen RC; Josephs KA
J Neurol; 2014 Jul; 261(7):1344-8. PubMed ID: 24760339
[TBL] [Abstract][Full Text] [Related]
32. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
[TBL] [Abstract][Full Text] [Related]
33. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
[TBL] [Abstract][Full Text] [Related]
34. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
35. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
[TBL] [Abstract][Full Text] [Related]
36. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease.
King A; Sweeney F; Bodi I; Troakes C; Maekawa S; Al-Sarraj S
Neuropathology; 2010 Aug; 30(4):408-19. PubMed ID: 20102526
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
[TBL] [Abstract][Full Text] [Related]
38. Autopsy-confirmed hippocampal-sparing Alzheimer's disease with delusional jealousy as initial manifestation.
Fujishiro H; Iritani S; Hattori M; Sekiguchi H; Matsunaga S; Habuchi C; Torii Y; Umeda K; Ozaki N; Yoshida M; Fujita K
Psychogeriatrics; 2015 Sep; 15(3):198-203. PubMed ID: 25737011
[TBL] [Abstract][Full Text] [Related]
39. A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology.
Corriveau-Lecavalier N; Botha H; Graff-Radford J; Switzer AR; Przybelski SA; Wiste HJ; Murray ME; Reichard RR; Dickson DW; Nguyen AT; Ramanan VK; McCarter SJ; Boeve BF; Machulda MM; Fields JA; Stricker NH; Nelson PT; Grothe MJ; Knopman DS; Lowe VJ; Petersen RC; Jack CR; Jones DT
medRxiv; 2023 Nov; ():. PubMed ID: 38045300
[TBL] [Abstract][Full Text] [Related]
40. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.
Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M
Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
